DE2727247A1 - Antibakterielles mittel - Google Patents

Antibakterielles mittel

Info

Publication number
DE2727247A1
DE2727247A1 DE19772727247 DE2727247A DE2727247A1 DE 2727247 A1 DE2727247 A1 DE 2727247A1 DE 19772727247 DE19772727247 DE 19772727247 DE 2727247 A DE2727247 A DE 2727247A DE 2727247 A1 DE2727247 A1 DE 2727247A1
Authority
DE
Germany
Prior art keywords
nocardicin
cycloserine
salt
antibacterial agent
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772727247
Other languages
German (de)
English (en)
Inventor
Hatsuo Aoki
Hiroshi Imanaka
Toyozi Nishiura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE2727247A1 publication Critical patent/DE2727247A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19772727247 1976-06-18 1977-06-16 Antibakterielles mittel Withdrawn DE2727247A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51072458A JPS6049602B2 (ja) 1976-06-18 1976-06-18 抗菌剤

Publications (1)

Publication Number Publication Date
DE2727247A1 true DE2727247A1 (de) 1977-12-29

Family

ID=13489871

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772727247 Withdrawn DE2727247A1 (de) 1976-06-18 1977-06-16 Antibakterielles mittel

Country Status (8)

Country Link
US (1) US4092411A (US20030199744A1-20031023-C00003.png)
JP (1) JPS6049602B2 (US20030199744A1-20031023-C00003.png)
AU (1) AU512893B2 (US20030199744A1-20031023-C00003.png)
BE (1) BE855766A (US20030199744A1-20031023-C00003.png)
DE (1) DE2727247A1 (US20030199744A1-20031023-C00003.png)
FR (1) FR2354768A1 (US20030199744A1-20031023-C00003.png)
GB (1) GB1524180A (US20030199744A1-20031023-C00003.png)
NL (1) NL7706461A (US20030199744A1-20031023-C00003.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196193A (en) * 1978-02-15 1980-04-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US20050009931A1 (en) * 2003-03-20 2005-01-13 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923977A (en) * 1972-08-29 1975-12-02 Fujisawa Pharmaceutical Co Antibiotic FR-1923 substance

Also Published As

Publication number Publication date
AU2620677A (en) 1978-12-21
US4092411A (en) 1978-05-30
AU512893B2 (en) 1980-11-06
JPS6049602B2 (ja) 1985-11-02
BE855766A (fr) 1977-12-16
GB1524180A (en) 1978-09-06
NL7706461A (nl) 1977-12-20
JPS52156931A (en) 1977-12-27
FR2354768B1 (US20030199744A1-20031023-C00003.png) 1981-01-09
FR2354768A1 (fr) 1978-01-13

Similar Documents

Publication Publication Date Title
DE69629691T2 (de) Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen
DE69934294T2 (de) Verwendung eines antimikrobiellen mittels so wie taurolidine oder taurultam zur herstellung eines arzneimittels zur behandlung einer nosokomialen mikrobiellen infektion
US4268503A (en) Antibacterial composition
DE2727247A1 (de) Antibakterielles mittel
DE2824610C2 (de) Arzneimittelgemisch aus einer Penicillansäure und aus einem Penicillin oder Cephalosporin
DE2942107A1 (de) Pharmazeutische zubereitung mit einer antibakteriellen wirkung und ihre verwendung zur behandlung von durch grampositive und gram-negative krankheitserregende keime hervorgerufene infektionen
DE2001731C3 (de) Erythromycinasparaginat, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Mittel
DE2508443C2 (de) Pharmazeutisches Mischpräparat mit antibiotischer Wirkung
US4330529A (en) Antibacterial composition
DE2910907C2 (de) Antibakterielles Mittel
DE2448564C3 (de) Verwendung von heterocyclischen Carbonsäuren
DE3104282C2 (US20030199744A1-20031023-C00003.png)
DE2312134C2 (de) Anthelmintikum
DE2650608A1 (de) Arzneipraeparat zur behandlung von mastitis bei milchvieh
DE1792223C3 (de) Arzneipräparate, geeignet zur Behandlung von durch gramnegative Bakterien hervorgerufenen Infektionen
US4196193A (en) Antibacterial composition
DE1900697A1 (de) Antibiotische Arzneimittel und Verfahren zum Herstellen von Antikoerpern
DE2760340C2 (US20030199744A1-20031023-C00003.png)
DE60106463T2 (de) Zusammensetzungen aus dalfopristin und quinupristin mit cefpirom
DE1939139C3 (de) n-Decylester der 4-Aminobuttersäure und hautverträgliches antiseptisches Mittel, enthaltend einen n-Alkylester der 4-Aminobuttersäure
DE1543831C (de) Verfahren zur Herstellung von Erythromy cinglutamat
EP0000891B1 (de) Synergistische Kombinationen von Penicillinen und sie enthaltende antibiotische Mittel
DE3445737A1 (de) Antibakterielle arzneimittelzusammensetzung
DE2758867A1 (de) Antimycobakterielle zubereitung und deren verwendung fuer die behandlung von mycobacteriose
CH666817A5 (de) Antimikrobiell wirkende arzneimittelpraeparate und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
8141 Disposal/no request for examination